Results 11 to 20 of about 1,138 (193)

Calcium sulphate and reduction in body weight: Evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006. [PDF]

EFSA J
Abstract Following an application from Mediconomics APS, submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Denmark, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim ...
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), Turck D, Bohn T, Cámara M, Castenmiller J, de Henauw S, Hirsch-Ernst KI, Jos A, Maciuk A, Mangelsdorf I, McNulty B, Naska A, Pentieva K, Thies F, Drenjančević I, Craciun I, Fiolet T, Siani A.   +18 more
europepmc   +2 more sources

Choline and contribution to normal liver function of the foetus and exclusively breastfed infants: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006. [PDF]

EFSA J, 2023
Abstract Following an application from Procter & Gamble BV pursuant to Article 14 of Regulation (EC) No 1924/2006 via the Competent Authority of Belgium, the Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to choline and contribution to normal liver ...
EFSA Panel on Nutrition, Novel Foods and Food allergens (NDA), Turck D, Bohn T, Castenmiller J, De Henauw S, Hirsch-Ernst KI, Knutsen HK, Maciuk A, Mangelsdorf I, McArdle HJ, Naska A, Pentieva K, Thies F, Tsabouri S, Vinceti M, Bresson JL, Fiolet T, Siani A.   +18 more
europepmc   +2 more sources

Analysis of 4616 clinical trial initial submissions received by the Medicines and Healthcare products Regulatory Agency between February 2019 and October 2023. [PDF]

Br J Clin Pharmacol
Aims This study aimed to analyse clinical trial initial submissions received by the MHRA between February 2019 and October 2023. Methods Data on submissions were extracted from the clinical trials unit data bank. The primary end‐point was the type of clinical trial initial submissions.
Manfrin A, Lee K, Pound J, Pirmohamed M, Raine J.   +4 more
europepmc   +2 more sources

Pacran®, a powder obtained from cranberries, and defence against bacterial pathogens in the lower urinary tract: Evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006. [PDF]

EFSA J
Abstract Following an application from Givaudan, submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Italy, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to ...
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), Turck D, Bohn T, Cámara M, Castenmiller J, de Henauw S, Hirsch-Ernst KI, Jos A, Maciuk A, Mangelsdorf I, McNulty B, Naska A, Pentieva K, Thies F, Craciun I, Fiolet T, Siani A.   +17 more
europepmc   +2 more sources

Why couple infertility is historically a female-driven problem? [PDF]

Andrology
Abstract Background The history of studies in the field of infertility represents a chapter of great interest in gender issues. Objectives This paper aims to delve deep into the historical roots of the aspect of gender inequality related to couple infertility, with a journey back in time, from classical antiquity to the contemporary age, reporting ...
Vignozzi L, Cipriani S, Lippi D.
europepmc   +2 more sources

Appethyl® and reduction of body weight: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006. [PDF]

EFSA J, 2023
Abstract Following an application from Greenleaf Medical AB, submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Sweden, the EFSA Panel on Nutrition, Novel Foods and Food allergens (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim ...
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), Turck D, Bohn T, Castenmiller J, De Henauw S, Hirsch-Ernst KI, Knutsen HK, Maciuk A, Mangelsdorf I, McArdle HJ, Naska A, Pentieva K, Thies F, Tsabouri S, Vinceti M, Bresson JL, Fiolet T, Siani A.   +18 more
europepmc   +2 more sources

Charting opportunities and guidelines for augmented reality in makerspaces through prototyping and co-design research

Computers & Education: X Reality, 2023
Makerspace environments are becoming popular project-based learning spaces where students interact with physical objects and peer collaboration, while developing 21st century skills and engaging with science, technology, engineering, and math (STEM ...
Iulian Radu, Josia Yuan, Xiaomeng Huang, Bertrand Schneider   +3 more
doaj   +1 more source

Oat beta-glucans and reduction of postprandial glucose peak: Evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006. [PDF]

EFSA J
Abstract Following an application from ScanOats, submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Ireland, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to ...
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), Turck D, Bohn T, Cámara M, Castenmiller J, de Henauw S, Hirsch-Ernst KI, Jos A, Maciuk A, Mangelsdorf I, McNulty B, Naska A, Pentieva K, Thies F, Drenjančević I, Craciun I, Siani A.   +17 more
europepmc   +2 more sources

Cloud BPM Application (Appian) Robotic Process Automation Capabilities

Asian Journal of Research in Computer Science, 2023
Cloud Business Process Management (BPM) platforms, such as Appian, have gained significant traction in recent years due to their ability to streamline and automate business processes.
Arjun Reddy Kunduru
semanticscholar   +1 more source

Designing augmented reality for makerspaces: Guidelines, lessons and mitigation strategies from 5+ years of AR educational projects

Computers & Education: X Reality, 2023
Makerspaces are a relatively recent type of open-ended environment where users learn through authentic problem solving and interactions with peers. Augmented reality (AR) technology can improve learning and collaboration in such spaces, but it is unclear
Iulian Radu, Bertrand Schneider
doaj   +1 more source